Claritev stock analysis
Want to see CTEV full AI Analyst Report?
Claritev (CTEV) Stock Price & Analysis
CTEV Stock Chart & Stats
- Day’s Range
- $26.77 - $28.32
- 52-Week Range
- $11.50 - $55.50
- Previous Close
- $26.90
- Volume
- N/A
- Average Volume (3M)
- 267.86K
- Market Cap
- $457.95M
- Enterprise Value
- $5.07B
- Total Cash (Recent Filing)
- $10.14M
- Total Debt (Recent Filing)
- $4.63B
- Price to Earnings (P/E)
- ―
- Beta
- 2.89
- Next Earnings
- Mar 02, 2027 (Est.)
- EPS Estimate
- -3.19
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Bookings And Diversification
Rapid bookings growth and broader demand across providers, public-sector, international, and TPA markets can reduce dependence on the core payer segment. A larger, more diversified pipeline supports recurring revenue expansion and improves the company’s ability to sustain growth over coming quarters.
Revenue Growth
Repeated year-over-year growth, a new trailing-twelve-month revenue milestone, and higher full-year guidance indicate improving commercial execution rather than a single-quarter improvement. Sustained top-line expansion should support operating leverage and provide a stronger base for future investment.
AI And Product Innovation
Combining multiple payment integrity and network capabilities into a Medicare Advantage offering can deepen customer relationships and broaden the addressable market. Production AI agents and healthcare intelligence products also create opportunities to improve workflows and strengthen differentiated data-driven services.
Bears Say
High Leverage And Negative Equity
Debt that nearly matches the asset base and negative equity leave the capital structure fragile, limiting financial flexibility during operating setbacks. High leverage can also constrain investment, increase refinancing exposure, and make it harder for improving cash flow to translate into durable shareholder value.
Persistent Net Losses
The large gap between positive operating profit and substantial net losses shows that non-operating costs or non-cash charges continue to absorb operating gains. Until bottom-line profitability improves, internal funding capacity remains limited and the company’s ability to reduce leverage is weakened.
NSA Regulatory Uncertainty
Unsettled NSA rules create uncertainty around a business area that has been an important source of claims volume and growth. Changes that affect dispute processes or economics could alter future demand, revenue visibility, and investment planning before the regulatory framework stabilizes.
Claritev News
CTEV FAQ
What was Claritev’s price range in the past 12 months?
What is Claritev’s market cap?
When is Claritev’s upcoming earnings report date?
How were Claritev’s earnings last quarter?
Is Claritev overvalued?
Does Claritev pay dividends?
What is Claritev’s EPS estimate?
How many shares outstanding does Claritev have?
What happened to Claritev’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Claritev?
What is the TipRanks Smart Score and how is it calculated?
Claritev Stock Smart Score
Company Description
Claritev
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Travis S. Dalton
- Employees
- 3,000
- Website
- www.claritev.com
- Address
- 7900 Tysons One Place, McLean, VA, 22102, US
Claritev (CTEV) Earnings & Revenues
CTEV Company Deck
CTEV Earnings Call
Earnings Call SentimentPositive
The call was strongly positive. Management reported revenue, adjusted EBITDA, bookings, pipeline, client additions, claims activity, and cash-flow expectations that exceeded or improved against prior expectations. The company also raised full-year guidance, projected at least $1.1 billion of revenue in 2027, and highlighted diversification, AI deployment, and product innovation. Offsetting concerns included lower adjusted EBITDA margin, declines in Network and Payment & Revenue Integrity revenue, third-quarter free cash flow usage, 7.7x net leverage, and continued uncertainty around NSA rule changes, but the positive developments significantly outweighed the challenges.
View all CTEV earnings summariesCTEV Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 5 | 6 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 8 | 0 | 4 |









